Interpreting Key Trials
Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study
Cleveland Clinic Journal of Medicine. 1997 May;64(5):234-327
Author(s):
Robert E. Hobbs, MD, FACC
Author and Disclosure Information
Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.
Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195